StreetInsider
Log in to your account:
Log in
Signup
Home
EPS Insider
Event Calendar
Conferences
Classic Site
Upgrade to SI Premium - Free Trial
Needham Reiterates Buy Rating on Medtronic, Inc. (MDT): "glad to see MDT increasingly pursue tuck-in acquisitions"
March 10, 2026 9:43 AM
Needham analyst Michael Matson reiterated a Buy rating and $120.00 price target on Medtronic, Inc. (NYSE: MDT)The analyst commented, "This ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
Categories
Analyst Comments
